Topic:
Pharma news
Latest Headlines
Latest Headlines
Troubled Pfizer blueprints biotech venture effort
Up to now, Pfizer's use of investment funds has followed a few narrow channels: Diagnostics, software and drug technology outfits that promised to help in their drug commercialization efforts. But
J&J makes big cuts at Alza and Scios
Two Bay area biotechs, Alza and Scios, are in line for some big layoffs as Johnson & Johnson slims down its pharma
Lilly developing biotech drugs the old-fashioned way
Pharma's biotech strategy is pretty clear: Buy companies or license in drugs and technology to get a leg up in the
J&J restructures pharma unit, laying off workers
Johnson & Johnson is taking the axe to its pharma division as it chops away at up to $750 million in costs. The company says it will continue to invest in new technologies, but faces some
